Table 2.
GC peak | RT min | Compounds | BB | CC | BC | CB |
---|---|---|---|---|---|---|
1 | 4.83 | Z-5,5-dimethyl-2-ethylidenetetrahydrofuran | 2.53 ± 1.47 | 2.43 ± 0.68 | 1.95 ± 0.64 | 2.43 ± 1.19 |
2 | 5.14 | 2-Heptanone | 0.40 ± 0.83 | 0.20 ± 0.30 | 0.07 ± 0.04 | 0.11 ± 0.13 |
3 | 5.24 | E-5-Hepten-2-one | 0.59 ± 0.44 | 0.54 ± 0.37 | 0.39 ± 0.20 | 0.55 ± 0.35 |
4 | 5.50 | E-5,5-dimethyl-2-ethylidenetetrahydrofuran | 0.95 ± 0.52 | 0.83 ± 0.24 | 0.70 ± 0.21 | 0.87 ± 0.41 |
5 | 5.55 | Z-2-pentenyl acetate | 0.05 ± 0.12a | 0.14 ± 0.11a,b,c | 0.03 ± 0.07b | 0.01 ± 0.02c |
6 | 5.77 | Dimethyl sulfone 6-Hydroxy-6-methyl-3-heptanone and | 10.5 ± 7.20a,b,c | 6.10 ± 2.12a,d | 5.62 ± 3.31b | 4.42 ± 2.53c,d |
7 | 7.43 | 5,5-dimethyl-2-ethyltetrahydrofuran-2ol | 57.7 ± 9.72 | 68.0 ± 10.3 | 67.3 ± 12.7 | 69.0 ± 11.6 |
8 | 8.45 | Benzyl alcohol | 6.34 ± 4.00 | 4.87 ± 3.59 | 5.79 ± 2.54 | 5.83 ± 2.10 |
9 | 8.88 | R,R-3,4-Dehydro-exo-brevicomin | 6.63 ± 3.36a,b,c | 2.53 ± 1.53a | 3.53 ± 2.01b | 2.18 ± 1.23b,c |
10 | 9.34 | Acetophenone | 0.19 ± 0.12 | 0.13 ± 0.05 | 0.23 ± 0.11 | 0.19 ± 0.06 |
11 | 9.48 | O-Toluidine | 0.65 ± 0.30a,b,c | 0.32 ± 0.25a | 0.21 ± 0.18b | 0.26 ± 0.21c |
12 | 10.36 | (S)-2-Sec-butyl-4,5-dihydrothiazole | 10.9 ± 6.50 | 13.2 ± 5.61 | 13.2 ± 6.99 | 13.1 ± 8.29 |
13 | 13.38 | N-Phenyl formanide | 2.55 ± 0.89a,b,c | 0.75 ± 0.51a | 0.93 ± 0.40b | 1.04 ± 0.28c |
Data are presented as mean ± SD, n = 8 for each group; compounds were identified using mass library (NIST 2002). a–fMeans in a row marked by a same superscript letter show significant differences (P < 0.05, using one-way ANOVA with LSD post hoc t-test or Kruskal–Wallis H with post hoc Mann–Whitney U test). BB: BALB/c strain; CC: C57BL/6 strain; BC: hybrid of BALB♀ × C57♂; CB: hybrid of C57♀ × BALB♂; RT: retention time.